The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.

Authors

Maria T. Acosta, George Washington UniversityFollow
Carrie E. Bearden, University of California - Los Angeles
F. Xavier Castellanos, New York UniversityFollow
Laurie Cutting, Vanderbilt University
Ype Elgersma, Erasmus University
Gerard A. Gioia, George Washington UniversityFollow
David H. Gutmann, Washington University in St. Louis
Yong-Seok Lee, University of California - Los Angeles
Eric Legius, University of Leuven
Maximilian Muenke, National Institutes of Health, Bethesda, MD
Kathryn North, Children's Hospital at Westmead
Luis F. Parada, University of Texas Southwestern
Kim Hunter-Schaedle, Children's Tumor Foundation
Nancy Ratner, Cincinnati Children's Hospital Medical Center
Alcino J. Silva, University of California - Los Angeles

Document Type

Journal Article

Publication Date

1-2013

Journal

American Journal of Medical Genetics, Part A

Volume

Volume 161, Issue 1

Inclusive Pages

236

Keywords

Learning Disorders--genetics; Neurofibromatosis 1--genetics; Translational Medical Research

APA Citation

Acosta, M. T., Bearden, C. E., Castellanos, X. F., Cutting, L., Elgersma, Y., Gioia, G., . . . Silva, A. J. (2013). Corrigendum to "the learning disabilities network (LeaDNet): Using neurofibromatosis type 1 [NF1] as a paradigm for translational research". American Journal of Medical Genetics, Part A, 161(1), 236.

Peer Reviewed

1